Global Botanical and plant-derived drugs market Size study, by source (Plant, Algae, Macroscopic fungi) By dosage form (Pills, Tablets, Capsules, Injection) By Therapeutic applications (Central Nervous System, Cardiovascular Diseases, Infectious Diseases, Respiratory Diseases) and Regional Forecasts 2019-2026

Global Botanical and plant-derived drugs market is valued approximately at USD 31.2 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 6.10% over the forecast period 2019-2026. Botanical drugs are derived from medicinal plants. Botanical drugs contain algae vegetable substance, and macroscopic fungi. Botanical and plant derived drugs help in treatment of various diseases, such as central nervous system disorders, infectious diseases cardiovascular diseases, and respiratory diseases. These drugs are used as an important component in medicine and therapies such as homeopathy and ayurvedic medicines. Increasing risk of side effects with the consumption of synthetic drugs such as gastrointestinal upsets, allergic reactions and more, these factors are increasing the demand for botanical and plant derived drugs. In addition, increasing incidences of chronic diseases are further contributing towards market growth. Increasing adoption of botanical and plant derived drugs in the treatment of respiratory and infectious disease is expected to create significant growth opportunity in the market over the forecast period. For instance, convallaria majalis plant extract is used in for the treatment of cardiovascular disease. Mytesi is a botanical drug approved for the symptom’s relief on noninfectious diarrhea in adults with HIV/AIDS. Also, introduction of medicines made from plants for the treatment of cardiac such as acetyldigoxin, adoniside are also rising adoption of botanical and plant derived drugs. However, stringent laws and regulations for approval of botanical drugs impedes the growth of the market over the forecast period of 2019-2026.
The regional analysis of global Botanical and plant-derived drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the high adoption of herbal drugs and technological advances. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as increasing awareness towards botanical and plant derived drugs and increasing prevalence of chronic diseases would create lucrative growth prospects for the Botanical and plant-derived drugs market across Asia-Pacific region.

Major market player included in this report are:
Bayer Healthcare LLC
Abott Laboratories
GlaxoSmithKline plc
Pfizer Inc, Sanofi
Actelion Pharmaceuticals Ltd
Aimil Pharmaceuticals India Ltd
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Concordia Pharmaceuticals Inc.
GW Pharmaceuticals plc

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By source:
Plant
Algae
Macroscopic fungi
By dosage form:
Pills
Tablets
Capsules
Injection
By Therapeutic applications:
Central Nervous System
Cardiovascular Diseases
Infectious Diseases
Respiratory Diseases
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Botanical and plant-derived drugs Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Geography Analysis:

The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

• North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
• Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
• Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
• Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
• Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

.